Ken Kato, MD, discussed the FDA approval of tislelizumab for the first-line treatment of esophageal squamous cell carcinoma.

Skin cancer is the most common cancer in the U.S., with risks influenced by factors like sun exposure, skin type, and income.

Nearly a decade after Erin Andrews was diagnosed with cervical cancer, the sportscaster told E! News she can't treat ...

Journal of the American Medical Association study provides further evidence that Multikine can treat unmet need in ~70% of ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: Arvinas (ARVN), 924% surge in interest Janux Therapeutics ...

CEL-SCI (CVM) announced that a third-party study published on March 6 in JAMA Oncology provided data that support Multikine’s use as a ...

Takeda is sharpening its oncology focus amid an R&D revamp. Sun Pharma will acquire Checkpoint Therapeutics and an ...

A Wakefield woman who survived cancer will host a showbusiness gala in the city to raise money for the charities that helped ...

With thousands of press releases published each week, it can be difficult to keep up with everything on PR Newswire. To help ...

Adlai Nortye Ltd. (NASDAQ:ANL – Get Free Report) saw a significant increase in short interest during the month of February. As of February 28th, there was short interest totalling 7,200 shares, an ...

There are three main types of ovarian cancer: epithelial, germ cell, and stromal. Learn about each type’s defining ...

Most cells in the body send out little messengers called extracellular vesicles that carry proteins, lipids, and other ...